FDA.reportPublic FDA data

HLA class I antigen tissue typing IVD, kit, complement-dependent cytotoxicity (CDC)

Definition
A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of one or multiple HLA class I antigens in a clinical specimen, using a complement-dependent cytotoxicity (CDC) method.
GUDID devices
7
Last updated
2019-04-02 21:21:59

Representative GUDID Devices#

Primary DI, Brand, Company table
Primary DIBrandCompanyModelPublished
07611969952717Lymphotype HLA-ABC 72Bio-Rad Medical Diagnostics GmbH8230202015-07-01
07611969952731Lymphotype HLA-AB 72 ANBio-Rad Medical Diagnostics GmbH8230232015-07-01
07611969952779Lymphotype HLA-ABC 120Bio-Rad Medical Diagnostics GmbH8230302015-07-01
07611969952786Lymphotype HLA-AB 120 specialBio-Rad Medical Diagnostics GmbH8230312015-07-01
07611969952830Lymphotype HLA-ABC 144 ItaliaBio-Rad Medical Diagnostics GmbH8230452015-07-01
07611969952854Lymphotype HLA-AB 144Bio-Rad Medical Diagnostics GmbH8230702015-07-01
07611969952908Lymphotype HLA-B27 specialBio-Rad Medical Diagnostics GmbH8231102015-07-01